Physician profile
Jonathan Gording
NPI 1487792701
$2,626.50
in general payments reported to CMS, 2019-2025
7 companies · $358 in 2025
The $358 reported for 2025 was more than what a typical Corneal and Contact Management provider received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,221 · 2020: $160 · 2021: $233 · 2022: $270 · 2023: $176 · 2024: $209 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $742.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,879.10 | 2019-2025 | Myday Contact Lens, Ortho-K Contact Lens, Synergeyes Contact Lens |
| Glaukos Corporation | $306.61 | 2020-2025 | Kxl System (Not Refurbished) |
| Alcon Vision LLC | $134.41 | 2021-2025 | Precision 1, Dailies Total1, Precision7 |
| Optos, INC. | $100.00 | 2019 | |
| Staar Surgical Company | $97.58 | 2019 | |
| Abiomed | $59.71 | 2021 | |
| Ivantis, INC | $49.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Gording listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.